Huntington's, Alzheimer's and Parkinson's Disease Research Shows Promise
Author: University of Leicester(i)
Published: 2011-06-02 : (Rev. 2018-01-26)
- Medical researchers may have uncovered a novel approach to treat Huntingtons disease an incurable and ultimately fatal neurodegenerative disease.
Trans-Atlantic team announces Huntington's disease breakthrough - New research offers promise of medical intervention for this devastating disorder.
Medical researchers may have uncovered a novel approach to treat an incurable and ultimately fatal neurodegenerative disease that affects hundreds of thousands of people.
Two international studies, one led by the University of Leicester, and the other a collaboration with Leicester led by scientists in the USA, hold out promise for slowing down the development of Huntington's disease - and potentially, Alzheimer's and Parkinson's diseases. The research, which is in its early stages, represents an important milestone in understanding these debilitating conditions.
Huntington's disease is a devastating inherited neurodegenerative disorder that is always fatal. The disorder of the central nervous system causes progressive degeneration of cells in the brain, slowly impairing a person's ability to walk, think, talk and reason. Approximately 1 in 10,000 individuals are affected worldwide.
In the world-famous Department of Genetics at Leicester, the groups of Dr Flaviano Giorgini and Prof Charalambos Kyriacou found that by genetically targeting a particular enzyme in fruit-flies, kynurenine 3-monooxygenase or KMO, they arrested the development of the neuro-degeneration associated with Huntington's disease. Furthermore by directly manipulating metabolites in the KMO cellular pathway with drugs, they could manipulate the symptoms that the flies displayed.
The fruit-fly study, to be published in Current Biology on 7 June, was also aided by the groups of Prof Robert Schwarcz who pioneered work in this area, and Dr Paul Muchowski (Gladstone Institutes, University of California, San Francisco). The two latter workers and Dr Giorgini have simultaneously published a paper in Cell, announcing a similar breakthrough in understanding the therapeutic relevance of KMO in transgenic mouse models of Huntington's and Alzheimer's diseases. www.gladstone.ucsf.edu/gladstone/site/publicaffairs/content/1/720
The fruit -fly research at Leicester took place over three years and was funded by the Huntington's Disease Association and the CHDI Foundation, Inc. Dr Giorgini, who led the UK study, states, "This work provides the first genetic and pharmacological evidence that inhibition of a particular enzyme - KMO - is protective in an animal model of this disease, and we have also found that targeting other points in this cellular pathway can improve Huntington's disease symptoms in fruit flies. This breakthrough is important as no drugs currently exist that halt progression or delay onset of Huntington's disease. We are tremendously excited about these studies, as we hope that they will have direct ramifications for Huntington's disease patients. Our work combined with the study in our companion publication in Cell, provides important confirmation of KMO inhibition as a potential therapeutic strategy for these individuals. As many KMO inhibitors are available, and more are being developed, it is hoped that such compounds can ultimately be tested in clinical trials for this as well as other neurodegenerative disorders."
The collaborating teams will continue their studies aimed at enhancing the development of medical intervention in Huntington's and other neurodegenerative disorders. Cath Stanley, Chief Executive of the Huntington's Disease Association, said: "This is an exciting piece of research that will offer hope to the many people affected by Huntington's disease."
(i)Source/Reference: University of Leicester. Disabled World makes no warranties or representations in connection therewith. Content may have been edited for style, clarity or length.
- 1 - Studying Chromosomes Centers May Reveal Link to Down Syndrome : Michigan Medicine - University of Michigan (2017/11/20)
- 2 - Chagas Disease T. cruzi and Dogs : Emory University (2010/07/12)
- 3 - Potential New Causes for TMAU - A Fishy Smelling Body Odor Disorder : Monell Chemical Senses Center (2017/02/15)
- 4 - Hope for Patients with Friedreich's Ataxia and Related Diseases : University of California, Davis (2017/06/08)
- 5 - New Bone Bandage Accelerates Repair of a Break : Duke University (2019/12/13)
- 6 - Folic Acid and Iodine in Australian and New Zealand Bread : Disabled World (2009/01/03)
- 7 - WellSpringboard - Crowdfunding Medical Breakthroughs : University of Michigan Health System (2016/06/10)
• Disabled World is strictly a news and information website provided for general informational purpose only and does not constitute medical advice. Materials presented are in no way meant to be a substitute for professional medical care by a qualified practitioner, nor should they be construed as such. Any 3rd party offering or advertising on disabled-world.com does not constitute endorsement by Disabled World.
• Please report outdated or inaccurate information to us.